Guru Ownership Trend
Guru Analysis for Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $202,591.26.
Top institutional holders include Renaissance Technologies (RenTech) and Murray Stahl.
Institutional sentiment is currently Bullish. This is evidenced by a $724,871.31 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 150.9%. Conversely, Murray Stahl reduced exposure by 4.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Lantern Pharma Inc. (LTRN)
Major holders include Renaissance Technologies (RenTech) ($1.21 M), Murray Stahl ($104,934). According to the latest reported data, 2 tracked investment managers collectively hold approximately 316,203 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $724,871.31, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited LTRN. The total reported sell value was $5,041.54.
Yes, 0 managers opened new positions in LTRN, and 1 increased their existing holdings. The total reported buy value was $729,912.85.